Health Care Professionals Log In


Media Professionals

Immediate access to important information, including the latest news and public relations contacts.

Special Announcements

Recent Earnings Releases

Related Links

Some of these documents are in PDF (portable document format). PDF files require Adobe acrobat Reader; Click here to download this free program.

2009 News

view complete archive

Click on a headline below to view the full news story.

You may also search our news archive by using keywords or dates (example: 4/25/2006).

Loading..



June 30, 2009

WYETH PHARMACEUTICALS AND CATALYST BIOSCIENCES ANNOUNCE AGREEMENT TO DEVELOP AND COMMERCIALIZE FACTOR VIIa PRODUCTS

June 18, 2009

Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders

June 16, 2009

Wyeth Announces Holder Right to Surrender Convertible Debentures

June 11, 2009

New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease

June 11, 2009

Wyeth Declares Common Stock Dividend

June 10, 2009

Wyeth Sets Webcast And Conference Call For 2009 Second Quarter Earnings

May 30, 2009

Wyeth Donates $100,000 to ASCO Cancer Foundation to Support Cancer Prevention and Care

May 29, 2009

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

May 7, 2009

Phase 3 Clinical Study of Relistor Presented at American Pain Society Meeting Showed Positive Activity for the Treatment of Opioid-Induced Constipation in Chronic, Non-Cancer Pain Patients

May 7, 2009

FDA Grants Priority Review Status to Prevnar 13 Marketing Application

April 29, 2009

Wyeth Reports Earnings Results for the 2009 First Quarter

April 27, 2009

Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture

April 23, 2009

Rwanda Becomes First Developing Nation to Introduce Vaccine for World's Leading Infectious Child Killer

April 23, 2009

Wyeth Declares Common and Preferred Stock Dividends

April 23, 2009

Wyeth Announces Full Redemption of $2 Convertible Preferred Stock

April 17, 2009

New Partnerships Added to World Federation of Hemophilia Twinning Program

April 2, 2009

Elan and Wyeth Plan to Amend Bapineuzumab Phase 3 Protocols

March 31, 2009

Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers

March 24, 2009

FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia

March 20, 2009

Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings

March 12, 2009

Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference

March 4, 2009

Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case

February 19, 2009

CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture

February 10, 2009

NCC and Wyeth Donation To Assist Cancer Patients in Latin America

January 26, 2009

Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company

January 26, 2009

Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter

January 22, 2009

Wyeth Declares Common and Preferred Stock Dividends

January 12, 2009

Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines

January 8, 2009

Wyeth to Present at the JP Morgan Healthcare Conference

January 5, 2009

Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

December 18, 2008

Wyeth Pharmaceuticals Acquires Thiakis Limited

December 12, 2008

Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer

December 9, 2008

Wyeth Sets Webcast and Conference Call for 2008 Fourth Quarter and Full Year Earnings